Income Statement
NUVATION BIO INC.
NUVB
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
62.90 | 7.87 | - | - | - | - |
|
Cost of Revenue
|
- | 7.08 | - | - | - | - |
|
Gross Profit
|
62.90 | 0.80 | - | - | - | - |
|
Operating Expenses
|
275.97 | 593.42 | 99.82 | 119.73 | 93.32 | 0.00 |
|
Research & Development
|
115.11 | 99.12 | 71.29 | 87.82 | 69.04 | - |
|
Selling, General & Administrative
|
151.56 | 69.23 | 28.53 | 31.92 | 24.28 | - |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-213.06 | -592.63 | -99.82 | -119.73 | -93.32 | - |
|
Non-Operating Income
|
8.44 | 24.69 | 24.02 | 15.54 | 6.47 | - |
|
Interest Income
|
21.43 | 27.06 | 24.61 | 7.45 | 2.96 | - |
|
Interest Expense
|
- | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
2.25 | - | - | - | - | - |
|
Income Before Tax
|
-204.63 | -567.94 | -75.80 | -104.20 | -86.85 | - |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - |
|
Net Income
|
-204.63 | -567.94 | -75.80 | -104.20 | -86.85 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-211.33 | -591.93 | -99.60 | -119.53 | -93.12 | 0.00 |
|
Earnings Per Share (Basic)
|
-0.60 | -2.11 | -0.35 | -0.48 | - | - |
|
Diluted EPS
|
-0.60 | -2.11 | -0.35 | -0.48 | - | - |
|
Weighted Average Shares
|
0.34 | 0.27 | 0.22 | 0.22 | - | - |
|
Diluted Weighted Avg Shares
|
0.34 | 0.27 | 0.22 | 0.22 | - | - |
|
Comprehensive Income
|
-205.39 | -567.55 | -70.10 | -108.54 | -89.59 | - |